RxSight, Inc. To Participate in the Truist Securities Medtech Conference

Rhea-AI Summary

RxSight, a company specializing in ophthalmic medical devices, announced its participation in the Truist Securities Medtech Conference. The event will include a fireside chat with RxSight's management on June 18, 2024, at 12:05 p.m. Pacific Time / 3:05 p.m. Eastern Time. A live and archived webcast of the presentation will be available on their investor relations website.

Positive

• Participation in a major industry conference can increase RxSight's visibility and investor interest.
• The fireside chat allows RxSight's management to directly communicate their vision and strategy to a targeted audience.

Negative

• No new financial or clinical data was provided in the announcement, limiting immediate investor insights.
• The PR lacks details on business developments or milestones, which may not satisfy investors looking for concrete updates.

ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference.

RxSight’s management is scheduled to participate in a fireside chat on Tuesday, June 18, 2024, at 12:05 p.m. Pacific Time / 3:05 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+™, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com

FAQ

What is the date and time of RxSight's presentation at the Truist Securities Medtech Conference?

RxSight's presentation is scheduled for June 18, 2024, at 12:05 p.m. Pacific Time / 3:05 p.m. Eastern Time.

How can interested parties access the RxSight presentation at the Truist Securities Medtech Conference?

A live and archived webcast of the presentation will be available on RxSight's investor relations website.

What is the purpose of RxSight's participation in the Truist Securities Medtech Conference?

RxSight aims to increase visibility and communicate its vision and strategy to investors and industry stakeholders.

What type of company is RxSight?

RxSight is an ophthalmic medical device company focused on providing customized vision solutions post-cataract surgery.